BD-2 and BD-3 Increase Skin Flap Survival in a Model of Ischemia and Pseudomonas Aeruginosa Infection

Detalhes bibliográficos
Autor(a) principal: Casal, D
Data de Publicação: 2019
Outros Autores: Iria, I, Ramalho, JS, Alves, S, Mota-Silva, E, Mascarenhas-Lemos, L, Pontinha, C, Guadalupe-Cabral, M, Ferreira-Silva, J, Ferraz-Oliveira, M, Vassilenko, V, Goyri-O'Neill, J, Pais, D, Videira, P
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.17/3265
Resumo: The main aim of this work was to study the usefulness of human β-defensins 2 (BD-2) and 3 (BD-3), which are part of the innate immune system, in the treatment of infected ischemic skin flaps. We investigated the effect of transducing rat ischemic skin flaps with lentiviral vectors encoding human BD-2, BD-3, or both BD-2 and BD-3, to increase flap survival in the context of a P. aeruginosa infection associated with a foreign body. The secondary endpoints assessed were: bacterial counts, and biofilm formation on the surface of the foreign body. A local ischemic environment was created by producing arterialized venous flaps in the left epigastric region of rats. Flaps were intentionally infected by placing underneath them two catheters with 105 CFU of P. aeruginosa before the surgical wounds were hermetically closed. Flap biopsies were performed 3 and 7 days post-operatively, and the specimens submitted to immunohistochemical analysis for BD-2 and BD-3, as well as to bacterial quantification. Subsequently, the catheter segments were analyzed with scanning electron microscopy (SEM). Flaps transduced with BD-2 and BD-3 showed expression of these defensins and presented increased flap survival. Rats transduced with BD-3 presented a net reduction in the number of P. aeruginosa on the surface of the foreign body and lesser biofilm formation.
id RCAP_c354a0f5bced3572f41cef39c1dce23e
oai_identifier_str oai:repositorio.chlc.pt:10400.17/3265
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling BD-2 and BD-3 Increase Skin Flap Survival in a Model of Ischemia and Pseudomonas Aeruginosa InfectionCHLC CPRCHLC PAT CLINAnimalsAnti-Bacterial Agents / metabolismAnti-Bacterial Agents / therapeutic useDisease Models, AnimalGenetic TherapyGenetic Vectors / therapeutic useGenetic Vectors / geneticsGraft SurvivalIschemia / complicationsPseudomonas Infections / complicationsMalePseudomonas Infections / therapyPseudomonas aeruginosa / drug effectsRatsRats, WistarSkin Transplantation / adverse effectsSurgical Flaps / adverse effectsSurgical Flaps / microbiologyTransduction, Geneticbeta-Defensins / geneticsbeta-Defensins / therapeutic useThe main aim of this work was to study the usefulness of human β-defensins 2 (BD-2) and 3 (BD-3), which are part of the innate immune system, in the treatment of infected ischemic skin flaps. We investigated the effect of transducing rat ischemic skin flaps with lentiviral vectors encoding human BD-2, BD-3, or both BD-2 and BD-3, to increase flap survival in the context of a P. aeruginosa infection associated with a foreign body. The secondary endpoints assessed were: bacterial counts, and biofilm formation on the surface of the foreign body. A local ischemic environment was created by producing arterialized venous flaps in the left epigastric region of rats. Flaps were intentionally infected by placing underneath them two catheters with 105 CFU of P. aeruginosa before the surgical wounds were hermetically closed. Flap biopsies were performed 3 and 7 days post-operatively, and the specimens submitted to immunohistochemical analysis for BD-2 and BD-3, as well as to bacterial quantification. Subsequently, the catheter segments were analyzed with scanning electron microscopy (SEM). Flaps transduced with BD-2 and BD-3 showed expression of these defensins and presented increased flap survival. Rats transduced with BD-3 presented a net reduction in the number of P. aeruginosa on the surface of the foreign body and lesser biofilm formation.Nature Publishing GroupRepositório do Centro Hospitalar Universitário de Lisboa Central, EPECasal, DIria, IRamalho, JSAlves, SMota-Silva, EMascarenhas-Lemos, LPontinha, CGuadalupe-Cabral, MFerreira-Silva, JFerraz-Oliveira, MVassilenko, VGoyri-O'Neill, JPais, DVideira, P2019-05-30T11:43:58Z2019-05-272019-05-27T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.17/3265engSci Rep. 2019 May 27;9(1):7854.10.1038/s41598-019-44153-yinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-10-28T10:28:50Zoai:repositorio.chlc.pt:10400.17/3265Portal AgregadorONGhttps://www.rcaap.pt/oai/openairemluisa.alvim@gmail.comopendoar:71602024-10-28T10:28:50Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv BD-2 and BD-3 Increase Skin Flap Survival in a Model of Ischemia and Pseudomonas Aeruginosa Infection
title BD-2 and BD-3 Increase Skin Flap Survival in a Model of Ischemia and Pseudomonas Aeruginosa Infection
spellingShingle BD-2 and BD-3 Increase Skin Flap Survival in a Model of Ischemia and Pseudomonas Aeruginosa Infection
Casal, D
CHLC CPR
CHLC PAT CLIN
Animals
Anti-Bacterial Agents / metabolism
Anti-Bacterial Agents / therapeutic use
Disease Models, Animal
Genetic Therapy
Genetic Vectors / therapeutic use
Genetic Vectors / genetics
Graft Survival
Ischemia / complications
Pseudomonas Infections / complications
Male
Pseudomonas Infections / therapy
Pseudomonas aeruginosa / drug effects
Rats
Rats, Wistar
Skin Transplantation / adverse effects
Surgical Flaps / adverse effects
Surgical Flaps / microbiology
Transduction, Genetic
beta-Defensins / genetics
beta-Defensins / therapeutic use
title_short BD-2 and BD-3 Increase Skin Flap Survival in a Model of Ischemia and Pseudomonas Aeruginosa Infection
title_full BD-2 and BD-3 Increase Skin Flap Survival in a Model of Ischemia and Pseudomonas Aeruginosa Infection
title_fullStr BD-2 and BD-3 Increase Skin Flap Survival in a Model of Ischemia and Pseudomonas Aeruginosa Infection
title_full_unstemmed BD-2 and BD-3 Increase Skin Flap Survival in a Model of Ischemia and Pseudomonas Aeruginosa Infection
title_sort BD-2 and BD-3 Increase Skin Flap Survival in a Model of Ischemia and Pseudomonas Aeruginosa Infection
author Casal, D
author_facet Casal, D
Iria, I
Ramalho, JS
Alves, S
Mota-Silva, E
Mascarenhas-Lemos, L
Pontinha, C
Guadalupe-Cabral, M
Ferreira-Silva, J
Ferraz-Oliveira, M
Vassilenko, V
Goyri-O'Neill, J
Pais, D
Videira, P
author_role author
author2 Iria, I
Ramalho, JS
Alves, S
Mota-Silva, E
Mascarenhas-Lemos, L
Pontinha, C
Guadalupe-Cabral, M
Ferreira-Silva, J
Ferraz-Oliveira, M
Vassilenko, V
Goyri-O'Neill, J
Pais, D
Videira, P
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório do Centro Hospitalar Universitário de Lisboa Central, EPE
dc.contributor.author.fl_str_mv Casal, D
Iria, I
Ramalho, JS
Alves, S
Mota-Silva, E
Mascarenhas-Lemos, L
Pontinha, C
Guadalupe-Cabral, M
Ferreira-Silva, J
Ferraz-Oliveira, M
Vassilenko, V
Goyri-O'Neill, J
Pais, D
Videira, P
dc.subject.por.fl_str_mv CHLC CPR
CHLC PAT CLIN
Animals
Anti-Bacterial Agents / metabolism
Anti-Bacterial Agents / therapeutic use
Disease Models, Animal
Genetic Therapy
Genetic Vectors / therapeutic use
Genetic Vectors / genetics
Graft Survival
Ischemia / complications
Pseudomonas Infections / complications
Male
Pseudomonas Infections / therapy
Pseudomonas aeruginosa / drug effects
Rats
Rats, Wistar
Skin Transplantation / adverse effects
Surgical Flaps / adverse effects
Surgical Flaps / microbiology
Transduction, Genetic
beta-Defensins / genetics
beta-Defensins / therapeutic use
topic CHLC CPR
CHLC PAT CLIN
Animals
Anti-Bacterial Agents / metabolism
Anti-Bacterial Agents / therapeutic use
Disease Models, Animal
Genetic Therapy
Genetic Vectors / therapeutic use
Genetic Vectors / genetics
Graft Survival
Ischemia / complications
Pseudomonas Infections / complications
Male
Pseudomonas Infections / therapy
Pseudomonas aeruginosa / drug effects
Rats
Rats, Wistar
Skin Transplantation / adverse effects
Surgical Flaps / adverse effects
Surgical Flaps / microbiology
Transduction, Genetic
beta-Defensins / genetics
beta-Defensins / therapeutic use
description The main aim of this work was to study the usefulness of human β-defensins 2 (BD-2) and 3 (BD-3), which are part of the innate immune system, in the treatment of infected ischemic skin flaps. We investigated the effect of transducing rat ischemic skin flaps with lentiviral vectors encoding human BD-2, BD-3, or both BD-2 and BD-3, to increase flap survival in the context of a P. aeruginosa infection associated with a foreign body. The secondary endpoints assessed were: bacterial counts, and biofilm formation on the surface of the foreign body. A local ischemic environment was created by producing arterialized venous flaps in the left epigastric region of rats. Flaps were intentionally infected by placing underneath them two catheters with 105 CFU of P. aeruginosa before the surgical wounds were hermetically closed. Flap biopsies were performed 3 and 7 days post-operatively, and the specimens submitted to immunohistochemical analysis for BD-2 and BD-3, as well as to bacterial quantification. Subsequently, the catheter segments were analyzed with scanning electron microscopy (SEM). Flaps transduced with BD-2 and BD-3 showed expression of these defensins and presented increased flap survival. Rats transduced with BD-3 presented a net reduction in the number of P. aeruginosa on the surface of the foreign body and lesser biofilm formation.
publishDate 2019
dc.date.none.fl_str_mv 2019-05-30T11:43:58Z
2019-05-27
2019-05-27T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.17/3265
url http://hdl.handle.net/10400.17/3265
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Sci Rep. 2019 May 27;9(1):7854.
10.1038/s41598-019-44153-y
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Nature Publishing Group
publisher.none.fl_str_mv Nature Publishing Group
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv mluisa.alvim@gmail.com
_version_ 1817548650836918272